Clinical Study

A Phase 3, Open-Label, 1-Year Study Of The Safety, Tolerability, And Need For Re-Treatment With Sage-217 In Adult Subjects With Major Depressive Disorder

Posted Date: Jan 25, 2021

  • Investigator: Caleb Adler
  • Specialties: Depression, Psychiatry/Psychology
  • Type of Study: Drug

This study is to determine the safety and tolerability of initial treatment and/or re-treatment(s) in adults with MDD experiencing a major depressive episode (MDE) .


Adults With Mdd Experiencing A Major Depressive Episode.


Depression, Mdd, Adults

For More Information:

Emily Rummelhoff

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.